EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sinonasal Histopathological Changes After 12 Months of Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps

Bartłomiej Kamiński iD, Dominika Ochab iD, Janusz Kopczyński, Piotr Łacwik iD, Magdalena Bętkowska, Stanisław Flaga iD, Cezary Pałczyński

Medical Sciences · 2026

DOI: 10.3390/medsci14060686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Bartłomiej Kamiński und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Maria Skłodowska-Curie District Hospital, 26-110 Skarżysko-Kamienna, Poland. Hauptthemen laut MEDLINE: Rhinosinusitis, Nasal Polyps, Antibodies, Monoclonal, Humanized, Rhinitis. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Dupilumab blocks the interleukin-4 receptor alpha (IL-4Rα) subunit, thereby inhibiting IL-4- and IL-13-mediated signaling, and is an effective treatment for severe chronic rhinosinusitis with nasal polyps (CRSwNP). This study assessed clinical response and histopathological changes reflecting eosinophilic inflammation and tissue remodeling after 12 months of dupilumab therapy.

Methods

This prospective pilot real-world study included 27 patients with severe CRSwNP. Paired sinonasal mucosal biopsies were obtained before treatment and after 12 months. Histopathological assessment included tissue eosinophilia, basement membrane thickness, subepithelial edema, tissue neutrophilia, and Charcot–Leyden crystals (CLCs). Clinical outcomes included Nasal Polyp Score (NPS), Sino-Nasal Outcome Test-22 (SNOT-22), and the 12-item Sniffin’ Sticks test.

Results

Median NPS decreased from 6.0 [5.5–7.0] to 1.0 [1.0–1.0] (p < 0.001), SNOT-22 from 73.1 ± 15.7 to 14.9 ± 10.3 (p < 0.001), and olfactory scores increased from 2.85 ± 2.46 to 7.54 ± 3.19 (p < 0.001). Tissue eosinophils decreased from 122 [81–323] to 36 [19.5–76] cells/mm2 (p < 0.001), basement membrane thickness from 6.0 [4.15–7.5] to 4.0 [3.15–5.0] µm (p = 0.0019), and subepithelial edema from grade 2 [2–3] to 1 [1–1] (p < 0.001). Tissue neutrophil counts did not change significantly, while CLC prevalence decreased from 7/27 (25.9%) to 0/27 (0%; p = 0.0156; Holm-adjusted p = 0.0469).

Conclusions

Twelve months of dupilumab therapy was associated with marked clinical improvement and significant histopathological changes in the sinonasal mucosa. These findings indicate that clinical improvement during treatment was accompanied by changes in eosinophilic inflammation and selected structural features of tissue remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinosinusitisNasal PolypsAntibodies, Monoclonal, HumanizedRhinitisSinusitisHumansFemaleMaleChronic DiseaseMiddle AgedAdultNasal MucosaProspective StudiesTreatment OutcomePilot Projects

Stichwörter der Autor:innen

CRSwNPCharcot–Leyden crystalschronic rhinosinusitis with nasal polypsdupilumabeosinophilstissue remodeling

Substanzen

Antibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • Department of Otolaryngology, Maria Skłodowska-Curie District Hospital, 26-110 Skarżysko-Kamienna, Poland.
  • Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland.
  • Clinical Division of Lung Diseases and Allergology, Holy Cross Centre for Lung Disease, 26-060 Czerwona Góra, Poland.
  • Department of Oncological Pathology, Holy Cross Cancer Centre, 25-734 Kielce, Poland.
  • AGH University of Krakow, Faculty of Mechanical Engineering and Robotics, 30-059 Krakow, Poland.

ORCID-Profile: Bartłomiej Kamiński, Dominika Ochab, Piotr Łacwik, Stanisław Flaga

Zitieren

APA

Kamiński, B., Ochab, D., Kopczyński, J., Łacwik, P., Bętkowska, M., Flaga, S., & Pałczyński, C. (2026). Sinonasal Histopathological Changes After 12 Months of Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps. Medical Sciences. https://doi.org/10.3390/medsci14060686

Vancouver

Kamiński B, Ochab D, Kopczyński J, Łacwik P, Bętkowska M, Flaga S, et al. Sinonasal Histopathological Changes After 12 Months of Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps. Medical Sciences. 2026. doi:10.3390/medsci14060686

BibTeX
@article{Kamiski2026,
  author = {Kamiński, Bartłomiej and Ochab, Dominika and Kopczyński, Janusz and Łacwik, Piotr and Bętkowska, Magdalena and Flaga, Stanisław and Pałczyński, Cezary},
  title = {Sinonasal Histopathological Changes After 12 Months of Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14060686}
}
Kostenlos starten →